. Pfizer, BioNTech Say COVID-19 Booster Shot Showed High Efficacy In Large Study « JO LEE MAGAZINE

Reuters – A booster dose of the COVID-19 vaccine developed by Pfizer Inc (PFE.N) and German partner BioNTech SE (22UAy.DE) restored efficacy to 95.6% against the virus, including the Delta variant, data released by the companies from a large study showed on Thursday. The companies said the trial…

More at Reuters

Comments are closed.